ECM
AMAG

Element Capital Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Element Capital Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-19,371
Closed -$249K – 861
2019
Q1 		$249K Buy
19,371
+891
+5% +$13.3K 0.01% 663
2018
Q4 		$281K Sell
18,480
-15,029
-45% -$286K 0.01% 470
2018
Q3 		$670K Buy
33,509
+14,037
+72% +$320K 0.01% 387
2018
Q2 		$380K Buy
+19,472
New +$431K 0.01% 468

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Element Capital Management's AMAG Position: Q2 2019 in Review

Element Capital Management sold out of AMAG Pharmaceuticals (AMAG) in Q2 2019, closing a stake of 19,371 shares — an estimated $249K sold.

Element Capital Management first reported a position in AMAG in Q2 2018 and held it in 4 quarters. The position peaked at $670K in Q3 2018. 170 funds tracked by Wall St. Rank hold AMAG as of Q2 2019.

  • Element Capital Management reported no remaining AMAG Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Element Capital Management sold 19,371 AMAG Pharmaceuticals shares in Q2 2019, an estimated $249K.
  • Element Capital Management first reported a position in AMAG Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • Element Capital Management's AMAG Pharmaceuticals position peaked at $670K in Q3 2018.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2019.

Based on Element Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.